从固态控制到预测精度:构建一个可部署的生态系统,用于迷幻疗法
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ACS medicinal chemistry letters
|February 18, 2026
概括
迷幻药物开发正在推进新的治疗系统. 创新包括优化药物稳定性和使用人工智能来预测患者的反应,解决迷幻医学的关键挑战.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 生物技术是生物技术.
背景情况:
- 迷幻药物开发正在发展,超越了传统的分子和经验方法.
- 翻译研究在制造,稳定性和预测治疗疗效方面面临瓶.
研究的目的:
- 通过两个专利申请,突出心理治疗系统的最新进展.
- 展示创新策略,以克服心理医学中的翻译挑战.
主要方法:
- 对lysergamide类似物进行固态优化,以提高可制造性和稳定性.
- 机器学习驱动的神经生理生物标志物的应用,以预测患者对迷幻疗法的反应.
主要成果:
- 专利申请显示,在制造稳定,可制造的迷幻药物配方方面取得了进展.
- 使用机器学习的预测生物标志物的开发增强了个性化的迷幻治疗方法.
结论:
- 迷幻医学正在向综合治疗系统迈进.
- 这些进展解决了关键的制造和患者分层挑战,为更广泛的临床应用铺平了道路.
相关概念视频
Hallucinogens and Psychedelics
771
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
771
CNS Stimulants: Psychedelic Agents
855
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
855
Modified-Release Drug Delivery Systems: Stimuli-Activated
26
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
26


